Research map: Serum Agalactosyl IgG Predicts Hepatocellular Carcinoma and All‐Cause Mortality After SVR in Advanced Chronic Hepatitis C

Back to the article

Papers in this map

  1. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement · Professor Gary S. Collins · 2015 · 4395 citations · Cited by this paper
  2. Evidence‐Based Clinical Practice Guidelines for Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) 2026 · 2026 · Related
  3. Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG · R. B. Parekh · 1985 · 1175 citations · Cited by this paper
  4. Efficacy and Safety of Stereotactic Body Radiation Therapy in Patients With Hepatocellular Carcinoma in the Caudate Lobe: A Comparative Study With Radiofrequency Ablation · 2026 · Related
  5. Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH‐HCC guidelines) 2019 update · Norihiro Kokudo · 2019 · 540 citations · Cited by this paper
  6. Rare Variants in PFIC‐Related Genes Among Adults With Intrahepatic Cholestasis · 2026 · Related
  7. Terminal sugars of Fc glycans influence antibody effector functions of IgGs · T. Shantha Raju · 2008 · 525 citations · Cited by this paper
  8. Stability and Variability of Symptom Burden in Primary Biliary Cholangitis: Insights From a Decade of Follow‐Up · 2026 · Related
  9. Aberrant IgG galactosylation precedes disease onset, correlates with disease activity, and is prevalent in autoantibodies in rheumatoid arthritis · Altan Ercan · 2010 · 245 citations · Cited by this paper
  10. Fragmentation Analysis of the MYC Enhancer in Cell‐Free DNA by qPCR for Early Detection of Hepatocellular Carcinoma · 2026 · Related
  11. Glycoform-dependent conformational alteration of the Fc region of human immunoglobulin G1 as revealed by NMR spectroscopy · Yoshiki Yamaguchi · 2005 · 204 citations · Cited by this paper
  12. Avacopan‐Associated Hepatobiliary Adverse Events and Vanishing Bile Duct Syndrome: A PMDA/JADER and FAERS Reporting‐Profile Comparison · 2026 · Related
  13. Functional diversification of IgGs through Fc glycosylation · Taia T. Wang · 2019 · 196 citations · Cited by this paper
  14. Serum Mac‐2 Binding Protein Glycan Isomer and Cerebral White Matter Injury in Older Adults: A Hepatic–Cerebral Link · 2026 · Related
  15. Glycosylation Profile of Immunoglobulin G Is Cross-Sectionally Associated With Cardiovascular Disease Risk Score and Subclinical Atherosclerosis in Two Independent Cohorts · Cristina Menni · 2018 · 130 citations · Cited by this paper
  16. Anti‐Integrin αvβ6 Autoantibodies as Diagnostic and Monitoring Biomarkers for Pediatric‐Onset Primary Sclerosing Cholangitis · 2026 · Related
  17. Low galactosylation of IgG associates with higher risk for future diagnosis of rheumatoid arthritis during 10 years of follow-up · Ivan Gudelj · 2018 · 100 citations · Cited by this paper
  18. Compensatory Hepatic Hypertrophy After Carbon Ion Radiotherapy for Hepatocellular Carcinoma: Factors Associated With Its Development and Relationship With Prognosis · 2026 · Related
  19. The importance of IgG glycosylation—What did we learn after analyzing over 100,000 individuals · Jasminka Krištić · 2024 · 70 citations · Cited by this paper
  20. Evolving Strategies in HBV Management: Insights From Updated International Guidelines · 2026 · Related
  21. Ongoing liver inflammation in patients with chronic hepatitis C and sustained virological response · Christoph Welsch · 2017 · 65 citations · Cited by this paper
  22. Lectin-based Immunoassay for Aberrant IgG Glycosylation as the Biomarker for Crohnʼs Disease · Shinichiro Shinzaki · 2012 · 47 citations · Cited by this paper
  23. N-Glycosylation Profiles of Immunoglobulin G and Future Cardiovascular Events · Rosângela Akemi Hoshi · 2024 · 35 citations · Cited by this paper
  24. Role of aberrant IgG glycosylation in the pathogenesis of inflammatory bowel disease · Eiji Miyoshi · 2015 · 32 citations · Cited by this paper
  25. Functional analysis of agalactosyl IgG in inflammatory bowel disease patients · Sachiko Nakajima · 2010 · 32 citations · Cited by this paper
  26. Dynamic α-fetoprotein, platelets and AST-to-platelet ratio index predict hepatocellular carcinoma in chronic hepatitis C patients with sustained virological response after antiviral therapy · Cheng‐Kun Wu · 2016 · 26 citations · Cited by this paper
  27. Hepatitis C Virus RNA Levels During Interferon-Free Combination Direct-Acting Antiviral Treatment in Registrational Trials: Table 1. · Patrick R. Harrington · 2015 · 18 citations · Cited by this paper
  28. IgG is associated with the asialoglycoprotein receptor in the human liver · Takashi Inamoto · 1991 · 14 citations · Cited by this paper
  29. Risk factors for liver‐related and non‐liver‐related mortality following a sustained virological response after direct‐acting antiviral treatment for hepatitis C virus infection in a real‐world cohort · Ritsuzo Kozuka · 2022 · 10 citations · Cited by this paper
  30. Non-invasive prediction of post-sustained virological response hepatocellular carcinoma in hepatitis C virus: A systematic review and meta-analysis · Han Ah Lee · 2024 · 10 citations · Cited by this paper
  31. Persistent liver inflammation in chronic hepatitis C patients with advanced fibrosis after direct-acting antivirals induced sustained virological response · Yun‐Cheng Hsieh · 2021 · 9 citations · Cited by this paper
  32. Agalactosyl IgG induces liver fibrogenesis via Fc gamma receptor 3a on human hepatic stellate cells · Cheng‐Hsun Ho · 2024 · 9 citations · Cited by this paper
  33. Sex Differences in Extrahepatic Outcomes After Antiviral Treatment for Hepatitis C · Jia Li · 2020 · 7 citations · Cited by this paper
  34. HCC prediction post SVR: Many tools yet limited generalizability! · Naveen Bhagat · 2022 · 7 citations · Cited by this paper
  35. Fucosylated haptoglobin is a novel predictive marker of hepatocellular carcinoma after hepatitis C virus elimination in patients with advanced liver fibrosis · Kumiko Shirai · 2022 · 7 citations · Cited by this paper
  36. Risk factors for liver‐related mortality of patients with hepatitis C virus after sustained virologic response to direct‐acting antiviral agents · Nobuhiro Hattori · 2022 · 5 citations · Cited by this paper
  37. Generation and validation of antibody 42B1 recognizing galactose-deficient IgG for diagnosis of chronic inflammatory diseases · Naoki Morishima · 2024 · 4 citations · Cited by this paper

Source: OpenAlex (CC0)